Adiponectin levels in non-obese first-degree relatives of type 2 diabetes patients and non-diabetic subjects: A 5-year follow-up study

Journal of International Medical Research

Volumn 38, Issue 3, 2010, Pages 792-802

  Liu, J ^a   Wang, F ^a   Cha, Y ^a   Chen, Z P ^a   Ding, H Y ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adiponectin; Atherosclerosis; First degree relatives; Risk factors; Type 2 diabetes patients

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PROTEIN BLOOD LEVEL; RELATIVE; RISK FACTOR; BLOOD; COMMON CAROTID ARTERY; COMPLICATION; FAMILY; GENETIC PREDISPOSITION; INTIMA; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; TUNICA MEDIA;

ADIPONECTIN; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; TUNICA INTIMA; TUNICA MEDIA;

EID: 77954784000     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800306     Document Type: Article

References (27)

1. Scherer PE, Williams S, Fogliano M, et al: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
2. Weyer C, Funahashi T, Tanaka S, et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
3. Lee S, Bacha F, Gungor N, et al: Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 2006; 29: 51-56.
4. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
5. Snehalatha C, Mukesh B, Simon M, et al: Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003; 26: 3226-3229.
6. Adamczak M, Wiecek A, Funahashi T, et al: Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003; 16: 72-75.
7. Zoccali C, Mallamaci F, Tripepi G, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141.
8. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764-2769.
9. Pellmé F, Smith U, Funahashi T, et al: Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003; 52: 1182-1186.
10. Jalovaara K, Santaniemi M, Timonen M, et al: Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism 2008; 57: 1130-1134.
11. Osei K, Gaillard T, Schuster D: Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res 2005; 13: 179-185.
12. Lihn AS, Østergard T, Nyholm B, et al: Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2003; 284: E443-E448.
13. Kriketos AD, Greenfield JR, Peake PW, et al: Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 2004; 27: 2033-2040.
14. Pimenta W, Korytkowski M, Mitrakou A, et al: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 1995; 273: 1855-1861.
15. van Haeften TW, Dubbeldam S, Zonderland ML, et al: Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 1998; 21: 278-282.
16. Cnop M, Vidal J, Hull RL, et al: Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007; 30: 677-682.
17. Osei K, Rhinesmith S, Gaillard T, et al: Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetesprevention. Diabetes Care 2004; 27: 1439-1446.
18. Gurrici S, Hartriyanti Y, Hautvast JG, et al: Differences in the relationship between body fat and body mass index between two different Indonesian ethnic groups: the effect of body build. Eur J Clin Nutr 1999; 53: 468-472.
19. Sorensen KE, Celermajer DS, Spiegelhalter DJ, et al: Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995; 74: 247-253.
20. Stumvoll M, Tschritter O, Fritsche A, et al: Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002; 51: 37-41.
21. Dullaart RP, de Vries R, van Tol A, et al: Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol 2007; 156: 387-394.
22. Pilz S, Horejsi R, Möller R, et al: Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005; 90: 4792-4796.
23. O'Leary DH, Polak JF, Kronmal RA, et al for the Cardiovascular Health Study Collaborative Research Group: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22.
24. Campuzano R, Moya JL, García-Lledó A, et al: Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J Hypertens 2006; 24: 1581-1588.
25. Nielsen MF, Nyholm B, Caumo A, et al: Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes. Diabetes 2000; 49: 2135-2141.
26. Lindsay RS, Funahashi T, Hanson RL, et al: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
27. Hotta K, Funahashi T, Bodkin NL, et al: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126-1133.